Loading
Latest filing published 01 Aug 2023 for DA32 Life Science Tech Acquisition Corp..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Deerfield Management Company, L.P. (Series C) discloses dealings in DA32 Life Science Tech Acquisition Corp. to SEC (Form 4). Between 30 July 2021 and 28 July 2023, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 1 purchase, €13.5M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
The newest entry dates from 1 August 2023: a transaction, in DA32 Life Science Tech Acquisition Corp. The last purchase on record was published on 3 August 2021, which is 1,908 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations